Full Schedule

Speaker: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Speaker: Wendy Bursey, RN CON(c) (she/her/hers) – Juravinski Cancer Centre

Co-Chair: Philippe Moreau, MD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Co-Chair: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Speaker: Tak W. Mak, PhD – Princess Margaret Cancer Centre at University Health Network

Panelist: Tak W. Mak, PhD – Princess Margaret Cancer Centre at University Health Network

Chair: Wendy Bursey, RN CON(c) (she/her/hers) – Juravinski Cancer Centre

Chair: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Speaker: Chantelle Hughes, RN, MNursSci (she/her/hers) – University College London Hosptial

Speaker: Mary Steinbach, DNP – Huntsman Cancer Institute/University of Utah

Speaker: Sara A. Scott, PharmD, BCOP (she/her/hers) – Winship Cancer Institute, Emory University

Abstract Presenter: Ty Simpson, RN (he/him/his) – The Alfred Hospital

Abstract Presenter: Dior Caruso, MN-NP Adult, CHPCN(C) – Princess Margaret Cancer Centre

Abstract Presenter: Jennifer Russell, MSc, BSc (Hons) – University College London Hospital

Chair: Vincent Rajkumar, MD – Mayo Clinic

Co-Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca

Speaker: Mehmet K. Samur, PhD – Dana Farber Cancer Institute, Harvard Medical School

Speaker: Madhav V. Dhodapkar, MD, (he/him/his) – Fred Hutch Cancer Center, Seattle, WA

Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Speaker: Natalie Callander, MD – University of Wisconsin

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Cancer Center Clínica Universidad de Navarra

Panelist: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Panelist: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Panelist: Peter Leif Bergsagel, MD – Mayo Clinic Arizona

Panelist: Chantelle Hughes, RN, MNursSci (she/her/hers) – University College London Hosptial

Panelist: Mary Steinbach, DNP – Huntsman Cancer Institute/University of Utah

Panelist: Sara A. Scott, PharmD, BCOP (she/her/hers) – Winship Cancer Institute, Emory University

Chair: Monica Morris, RN, MSc – Myeloma UK

Chair: Tracy King, PhD, MSc, RN (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital The University of Sydney

Speaker: Margaret McNeely, PhD (she/her/hers) – University of Alberta

Abstract Presenter: Jenna Tate, Master of Science in Advanced Clinical Practice, Registered Nurse (Adult) – Leeds Teaching Hospitals

Abstract Presenter: Donna D. Catamero, ANP-BC – Mount Sinai Hospital

Abstract Presenter: Daniela Klarica, NP – Alfred Health

Speaker: Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Moderator: Tracy King, PhD, MSc, RN (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital The University of Sydney

Panelist: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Panelist: Margaret McNeely, PhD (she/her/hers) – University of Alberta

Panelist: Tina M. Crosbie, BSc. (Pharm), ACPR, RPh (she/her/hers) – The Ottawa Hospital

Co-Chair: Rafat Abonour, Professor – Indiana University School of Medicine

Co-Chair: Meral Beksac, MD (she/her/hers) – Istinye University Ankara Liv Hospital, Department of Hematology

Abstract Presenter: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Abstract Presenter: Hira Mian, MD (she/her/hers) – McMaster University, Hamilton, ON, Canada

Abstract Presenter: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Abstract Presenter: Meera Mohan, MD – Medical College of Wisconsin

Abstract Presenter: Hang Quach, MBBS(Hons) FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Co-Chair: Manoj Bhasin, PhD – Emory University

Co-Chair: Jill Corre, PharmD PhD (she/her/hers) – Unité de Génomique du Myélome, University Hospital, IUCT-Oncopole, CRCT, Toulouse, France

Abstract Presenter: Jeremy Er, Bmed Sci, MBBS, FRACP, FRCPA – Hawkins laboratory, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia Clinical haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

Abstract Presenter: Francesco Maura, MD – Memorial Sloan Kettering

Abstract Presenter: Elena Maroto Martin, PhD (she/her/hers) – Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School

Abstract Presenter: Oliver Van Oekelen, MD, PhD – Icahn School of Medicine at Mount Sinai

Abstract Presenter: Tarek H. Mouhieddine, MD (he/him/his) – Dana-Farber Cancer Institute

Faculty: Efstathios Kastritis, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Faculty: Angela Dispenzieri, MD – Mayo Clinic Rochester

Faculty: Ramon Garcia Sanz, PhD (he/him/his) – Dept. of Hematology, Gregorio Marañón General University Hospital

Faculty: Victor H. Jimenez Zepeda, MD – Arthur JE Child Comprehensive Cancer Center

Faculty: Ben Derman, MD – University of Chicago

Faculty: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)

Co-Chair: Hartmut Goldschmidt, MD (he/him/his) – Internal Medicine V, GMMG Study Group at University Hospital Heidelberg, Heidelberg, Germany

Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre

Abstract Presenter: Rongfang Wei, PhD – Department of Hematology, The Eighth Affiliated Hospital, Sun Yat-sen University

Abstract Presenter: Maria Josic, MS – Pfizer

Abstract Presenter: Carlyn Rose Tan, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center

Abstract Presenter: Michael D. Amatangelo, PhD – Bristol Myers Squibb, Summit, NJ, USA

Abstract Presenter: Uday Yanamandra, MD (DM) – AFMC , Pune

Abstract Presenter: William C. Pilcher, Jr., BsC (he/him/his) – Emory University

Abstract Presenter: Yuntong Liu, liuyuntong@ihcam.ac.cn – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Abstract Presenter: Amandeep Godara, MD – University of Utah

Speaker: Monica Morris, RN, MSc – Myeloma UK

Chair: Luciano J. Costa, MD – University of Alabama Birmingham Hospital

Speaker: Krina K. Patel, MD, MSc (she/her/hers) – Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center

Speaker: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Speaker: Luciano J. Costa, MD – University of Alabama Birmingham Hospital

Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT

Speaker: Joshua Richter, MD – Icahn School of Medicine at Mount Sinai

Speaker: Luciano J. Costa, MD – University of Alabama Birmingham Hospital

Speaker: Luciano J. Costa, MD – University of Alabama Birmingham Hospital

Chair: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Co-Chair: Francesca Gay, MD (she/her/hers) – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Speaker: Aurore Perrot, MD, PhD – University of Toulouse, University Hospital Department of Hematology, IUCT Oncopole, CRCT, Toulouse, France

Speaker: Martin F. Kaiser, MD, FRCP, FRCPath (he/him/his) – The Institute of Cancer Research; Royal Marsden Hospital

Speaker: Ashley Rosko, MD (she/her/hers) – The Ohio State University

Speaker: Sonja Zweegman, MD, PhD – Amsterdam UMC

Panelist: Hira Mian, MD (she/her/hers) – McMaster University, Hamilton, ON, Canada

Panelist: Gordon Cook, PhD, DSc – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Panelist: Arleigh McCurdy, MD MHA FRCPC – The Ottawa Hospital, University of Ottawa, Canada

Co-Chair: Andrzej Jakubowiak, MD, PhD – The University of Chicago

Co-Chair: Robert Z. Orlowski, MD, PhD (he/him/his) – Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center

Abstract Presenter: Marina Hajiyianni, MD – Heidelberg Myeloma Center, Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany

Abstract Presenter: Aaron S. Rosenberg, MD, MS – UC Davis Comprehensive Cancer Center

Abstract Presenter: Marco Talarico, marco.talarico – Università di Bologna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli"

Abstract Presenter: Hira Mian, MD (she/her/hers) – McMaster University, Hamilton, ON, Canada

Abstract Presenter: Alissa Visram, MD, MPH – Juravinski Cancer Centre / Hamilton Health Sciences

Co-Chair: Francesco Maura, MD – Memorial Sloan Kettering

Co-Chair: Diana Cirstea, MD – Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School

Abstract Presenter: Anjana Anilkumar Sithara, MS – University of Ostrava

Abstract Presenter: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany

Abstract Presenter: Anna Besschetnova, PhD (she/her/hers) – Dana-Farber Cancer Institute

Abstract Presenter: Joshua Rivera, PhD – Dana-Farber Cancer Institute

Abstract Presenter: Denis J. Ohlstrom (he/him/his) – Georgia Institute of Technology

Co-Chair: Vincent Rajkumar, MD – Mayo Clinic

Co-Chair: Joan Blade, PhD (he/him/his) – Hospital Clinic de Barcelona

Speaker: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Speaker: Noopur Raje, MD – Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Speaker: Josefine Krüger, MD – Columbia University Irving Medical Center

Speaker: Sara Gandolfi, MD, PhD – University of Helsinki